Ulo Palm

Ulo Palm

Director/Board Member chez ANSI National Accreditation Board LLC

Fortune : 323 $ au 31/03/2024

Health Technology
Consumer Services
Commercial Services

Profil

Ulo Palm is currently a Director at ANSI National Accreditation Board LLC, Ordaos, Inc., and a Senior Member at American Society For Quality, Inc. Previously, he worked as Secretary & Director at Transcelerate Biopharma, Inc. from 2016 to 2020, and as Senior Vice President at Allergan, Inc. from 2015 to 2020.
He also held senior positions at Forest Laboratories, Inc. and Novartis AG.
Additionally, he served as Chief Medical Officer at Vaxxinity, Inc. Mr. Palm holds a doctorate from Freie Universität Berlin and an MBA from AKAD University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/04/2023 450 ( 0,00% ) 323 $ 31/03/2024

Postes actifs de Ulo Palm

SociétésPosteDébut
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -
Tous les postes actifs de Ulo Palm

Anciens postes connus de Ulo Palm

SociétésPosteFin
VAXXINITY, INC. Chief Tech/Sci/R&D Officer 01/10/2023
ALLERGAN, INC. Corporate Officer/Principal 01/05/2020
Director/Board Member 01/05/2020
NOVARTIS AG Chief Tech/Sci/R&D Officer -
FOREST LABORATORIES, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Ulo Palm

Formation de Ulo Palm

Freie Universität Berlin Doctorate Degree
AKAD University Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ulo Palm

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
NOVARTIS AG

Health Technology

VAXXINITY, INC.

Health Technology

Entreprise privées6

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés